胰十二指肠切除术后胰瘘预防策略的优化应用研究
该研究基于18家国际机构2000至2024年的7128例胰十二指肠切除术数据,分析引流、支架、奥曲肽、胰胃吻合和封堵剂等策略及其组合与术后胰瘘的关系。结果显示,支架、奥曲肽、胰胃吻合和封堵剂单独使用与胰瘘增加相关,而按瘘风险评分分层选择引流或引流+支架可改善结局,且提高对优化策略的依从性与降低外科医生层面胰瘘率相关。
要点
- 中风险患者单用引流胰瘘率13.1%优于19.8%,高风险患者引流+支架23.7%优于38.5%。
- 支架、奥曲肽、胰胃吻合和封堵剂单独使用与胰瘘增加相关,引流单独使用与胰瘘无关。
- 优化策略仅在32%患者中应用,普遍采用联合早期拔管可望消除三分之一至半数胰瘘。
核心结论
- 许多常用的胰瘘预防措施实际无效,而本研究中识别的优化策略应用不足,仅在32%患者中使用。
- 按瘘风险评分分层简化并定制化应用预防策略可降低顽固的胰瘘率,推动胰瘘预防的个体化。
研究设计与样本
- 回顾性多中心队列研究,纳入18家国际机构2000至2024年间的7128例胰十二指肠切除术,均具有完整胰瘘、瘘风险评分和预防策略数据。
- 分析的技术包括引流、支架、奥曲肽、胰胃吻合和封堵剂,并按瘘风险评分分层统计策略组合的胰瘘率,同时评估早期拔管(术后≤4天)的附加效应。
主要发现
- 总体胰瘘率为15.1%。
- 预防策略应用率:引流94.0%,支架37.4%,奥曲肽21.2%,胰胃吻合3.5%,封堵剂3.3%。
- 单独分析时,引流与胰瘘无关,而支架、奥曲肽、胰胃吻合和封堵剂与胰瘘增加相关。
- 风险调整后,在27种观察到的策略组合中呈现差异:可忽略和低风险评分患者中,无策略优于省略;中风险评分患者单用引流最佳(胰瘘率13.1% vs. 19.8%,P<0.001);高风险评分患者引流+支架最佳(23.7% vs. 38.5%,P<0.001)。
- 提高对优化策略的依从性与改善外科医生实践层面的胰瘘率相关(P=0.034)。
临床怎么用
- 根据瘘风险评分分层选择胰瘘预防策略:可忽略和低风险患者可考虑省略预防措施,中风险患者单用引流,高风险患者采用引流+支架。
- 考虑早期拔管(术后≤4天)作为附加措施以进一步降低胰瘘率。
局限性
- 研究为回顾性设计,结果可能受混杂因素影响。
- 部分预防策略(如胰胃吻合和封堵剂)应用率较低,可能限制其分析效力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To identify optimal approaches to fistula mitigation for pancreatoduodenectomy. BACKGROUND: Postoperative Pancreatic Fistula (POPF) is the most consequential complication following pancreatoduodenectomy (PD). To date, the various POPF prevention methods have been investigated predominantly in isolation; however, the complexity of PD demands studying the interplay between approaches. METHODS: 7128 PDs with complete POPF, Fistula Risk Score (FRS), and mitigation data were performed from 2000-2024 between 18 international institutions. Techniques analyzed were: drains, stents, octreotide, pancreatogastrostomy, and sealants. POPF was tabulated for strategy combinations, accounting for FRS. The additive effect of early drain removal (EDR; POD≤4) was assessed. RESULTS: The fistula rate was 15.1%. Mitigation application rates were drains=94.0%; stents=37.4%; octreotide=21.2%; pancreatogastrostomy=3.5%; and sealants=3.3%. Analyzed individually, drains were not associated with POPF, while stents, octreotide, pancreatogastrostomy, and sealants were associated with increased POPF. Risk adjustment revealed nuance among the 27 observed mitigation combinations. For Negligible and Low FRS patients, no approach improved upon omission. Drain-alone was best for Moderate FRS patients (POPF: 13.1% vs. 19.8%, P <0.001). Best outcomes for High FRS patients were achieved by employing Drain+Stent (23.7% vs. 38.5%, P <0.001). These results inform a "playbook" of optimal management. Increased adherence to these tenets was associated with improved surgeon practice-level fistula rates ( P =0.034). Universal adoption of optimal fistula mitigation projects to eliminate from one-third of fistulas, up to one-half when incorporating EDR. CONCLUSION: This robust experience indicates that many frequently employed fistula mitigation tactics are actually ineffective. Conversely, the optimal approaches identified herein are underutilized-in just 32% of patients. Simplified, tailored application can drive down stubborn fistula rates, enhance care, and move toward personalized medicine for fistula prevention.
引用
- Judish MM, Vollmer CM. Elucidating the Optimal Use of Mitigation Strategies for Improving Pancreatic Fistula Rates after Pancreatoduodenectomy. Ann Surg. 2026. PMID: 41382325. doi:10.1097/SLA.0000000000006995
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。